期刊文献+

JAK2阳性骨髓增殖性肿瘤患者65例临床特征分析 被引量:2

原文传递
导出
摘要 骨髓增殖性肿瘤(MPNs)是指分化相对成熟的一系或多系骨髓细胞不断地克隆性增殖所致的一组肿瘤性疾病,血常规检查结果可表现为一系或多系血细胞增生,表现为WBC计数、Hb、PLT计数异常,伴肝脏、脾脏或淋巴结肿大。其临床表现具有明显的异质性,许多患者无特殊表现或以心脑血管疾病就诊[1],容易被忽视。MPNs在治疗上应注重稳定外周血象,预防并发症,延缓疾病进展。我们对我院近5年收治的MPNs患者的临床特点及实验室检查结果进行回顾性分析,探讨JAK2阳性骨髓增殖性肿瘤的临床特征,以期提高对此类疾病的认识,为其诊断和预后提供更直接的依据。
出处 《临床内科杂志》 CAS 2020年第10期737-739,共3页 Journal of Clinical Internal Medicine
  • 相关文献

参考文献9

二级参考文献77

  • 1Mesa RA, Verstovsek S, Cervantes F, et al. Primary myelofibro- sis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT) IJ]. Leuk Res, 2007, 31 (6):737- 740.
  • 2Emanuel RM, Dueck AC, Geyer HL, et al. Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs ~ J ]. J Clin Oncol, 2012, 30(33):4098-4103.
  • 3Thiele J, Kvasnicka HM, Facchetti F, et al. European consensus on grading bone marrow fibrosis and assessment of cellularity [J]. Haematologica, 2005, 90(8):1128-1132.
  • 4Tefferi A, Vardiman JW. Classification and diagnosis of myelo- proliferative neoplasms: the 2008 World Health Organization cri- teria and point-of-care diagnostic algorithms [J]. Leukemia, 2008, 22 ( 1 ): 14-22.
  • 5Tefferi A, Thiele J, Vannuechi AM, et al. An overview on CALR and CSF3R mutations and a proposal for revision of WHO diag- nostic eriteria for myeloproliferative neoplasms [Jl. Leukemia, 2014, 28(7):1407-1413.
  • 6Cervantes F, Dupriez B, Pereira A, et al. New prognostic scoring system for primary myelofibrosis based on a study of the Inter- national Working Group for Myelofibrosis Research and Treat- ment[J]. Blood, 2009, 113( 13): 2895-2901.
  • 7Passamonti F, Cervantes F, Vannucchi AM, et al. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) IJ~. Blood, 2010, 115(9):1703-1708.
  • 8Gangat N, Caramazza D, Vaidya R, et al. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status I J]. J Clin Oncol, 2011, 29(4):392-397.
  • 9Xu Z, Gale RP, Zhang Y, et al. Unique features of primary myelofibrosis in Chinese I J ]. Blood, 2012, 119 ( 11 ) :2469-2473.
  • 10Barosi G, Ambrosetti A, Finelli C, et al. The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia~J~. Br J Haematol, 1999, 104(4):730-737.

共引文献176

同被引文献19

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部